Yüklüyor......
Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
BACKGROUND: The prognosis of hepatocellular carcinoma remains poor even after curative resection and it has no effective adjuvant therapy. AIM: This meta-analysis aimed to assess efficacy of sorafenib as adjuvant therapy for patients with hepatocellular carcinoma after resection. MATERIALS AND METHO...
Kaydedildi:
| Yayımlandı: | Oncotarget |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Impact Journals LLC
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5752555/ https://ncbi.nlm.nih.gov/pubmed/29312642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21299 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|